Skip to main content
An official website of the United States government
Español
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

multiple endocrine adenomatosis type 2

(MUL-tih-pul EN-doh-krin A-deh-NOH-muh-TOH-sis ...)
A rare, genetic disorder that affects the endocrine glands and can cause tumors in the thyroid gland, parathyroid glands, and adrenal glands. The affected endocrine glands may make high levels of hormones, which can lead to other medical problems such as high blood pressure and kidney stones. Multiple endocrine adenomatosis type 2 is caused by a mutation (change) in a gene called RET, and is divided into three subtypes (MEN2A, MEN2B, and FMTC). People with all subtypes of multiple endocrine adenomatosis type 2 have an increased risk of medullary thyroid cancer, pheochromocytoma, and parathyroid gland cancer. Also called MEN2, MEN2 syndrome, and multiple endocrine neoplasia type 2 syndrome.
Search NCI's Dictionary of Cancer Terms